Raymond James & Associates’s Trevi Therapeutics TRVI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$319K	Buy	95,383 +85,383	+854%	+$285K	﹤0.01%	3351
2024 Q2	$29.8K	Hold	10,000	–	–	﹤0.01%	3806
2024 Q1	$34.5K	Buy	+10,000	New	+$34.5K	﹤0.01%	3794